The Use of Antibody-drug Conjugates in Treating Advanced Urothelial Cancer
Dr. Daniel P. Petrylak discusses using antibody-drug conjugates (ADCs) in the treatment of advanced urothelial cancer.
Read MoreSelect Page
Posted by Daniel P. Petrylak, MD | Dec 2022
Dr. Daniel P. Petrylak discusses using antibody-drug conjugates (ADCs) in the treatment of advanced urothelial cancer.
Read MorePosted by Donna E. Hansel, MD, PhD | Dec 2022
Donna E. Hansel, MD, PhD delves into the molecular and genetic differences that define Upper tract urothelial carcinoma (UTUC).
Read MorePosted by Thomas Hope, MD | Nov 2022
In this 10-minute video, Thomas Hope, MD, Assistant Professor in Abdominal Imaging and Nuclear Medicine in the Department of Radiology at the University of California, San Francisco, discusses the appropriate use criteria (AUC) of PSMA PET in clinical practice. He summarizes the guidelines for the appropriate use of PSMA PET and delves into the studies that inform them.
Read MorePosted by Brian J. Flynn, MD | Nov 2022
In this 21-minute video, Brian J. Flynn, MD, Co-Director of Female Pelvic Medicine and Reconstructive Surgery, Reconstructive Urology, and associate professor at the University of Colorado, discusses Posterior Urethral Stenosis (PUS) after prostate cancer therapy and the existing and developing techniques used to address it. He then examines the various treatments used for PUS, such as dilation or transurethral incision (TUI), and considers the advantages and disadvantages of each technique.
Read MorePosted by Neil H. Baum, MD | Nov 2022
In this 7-minute video, Grand Rounds in Urology Contributing Editor Neil H. Baum, MD, Professor of Urology at Tulane Medical School, discusses the use of disposable cystoscopes to improve physician productivity and efficiency without additional overhead or compromising patient care.
Read More